Nanoparticle-and microsphere-based drug delivery systems (DDSs) have attracted wide
attention in cancer therapy; those DDSs that are responsive to tumor environment can …

Development of nanocarriers, which can selectively accumulate and remain within the tumor
tissue matrix, is beneficial for non-invasive cancer diagnosis and therapy. In this study, a …

Tumor‐cell‐derived microparticles (MPs) can function as anticancer drug‐delivery carriers.
However, short blood circulation time, large‐size‐induced insufficient tumor accumulation …

Nano-sized biocompatible and biodegradable polymersomes were prepared based on poly
(D, L-lactide)-block-poly (2-methacryloyloxyethyl phosphorylcholine)(PLA-b-PMPC) diblock …

The important characteristics of a nanoparticle-based anticancer drug delivery system at
least include high stability in blood, highly efficient tumor cellular uptake and stimuli …

Nanoparticles (NPs) with high drug loading and pH-responsivity were prepared by
nanoprecipitation of a hydrophobic polymer-drug conjugate (PDC). The PDC, polylactide …

Biodegradable micelles were prepared from poly (ε-caprolactone)-g-poly (2-hydroxyethyl
methacrylate)(PCL-g-PHEMA) graft copolymers and investigated for controlled release of …

Biodegradable nanoparticles have been well studied as biocompatible delivery systems.
Nanoparticles of less than 200 nm in size can facilitate the passive targeting of drugs to …

Background Two methoxyl poly (ethylene glycol)-poly (L-histidine)-poly (L-lactide)(mPEG-
PH-PLLA) triblock copolymers with different poly (L-histidine) chain lengths were …

The application of nanoparticle-based delivery systems is limited by uncontrolled drug
release, limited tumor penetration, and poor stability. To solve these problems, a tumor …